Mortality has improved in RA, but we must remain vigilant. Response to: 'Early intensive treatment normalises excess mortality in ACPA-negative RA but not in ACPA-positive RA' by Matthijssen et al

Ann Rheum Dis. 2020 Oct;79(10):e125. doi: 10.1136/annrheumdis-2019-215863. Epub 2019 Jul 8.
No abstract available

Publication types

  • Comment

MeSH terms

  • Anti-Citrullinated Protein Antibodies
  • Arthritis, Rheumatoid* / drug therapy
  • Cohort Studies
  • Follow-Up Studies
  • Humans

Substances

  • Anti-Citrullinated Protein Antibodies